GEORGE CHOLANKERIL

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address6620 MAIN
Houston, TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Konyn P, Perumpail BJ, Wijarnpreecha K, Cholankeril G, Ahmed A, Kim D. Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States. Expert Rev Gastroenterol Hepatol. 2024 Jan-Feb; 18(1-3):113-119. PMID: 38353612.
      Citations:    Fields:    Translation:HumansPHPublic Health
    2. Cholankeril G, Kanwal F. Reply to: "Longitudinal changes in fatty liver index are associated with risk of hepatocellular carcinoma: A nationwide cohort study in Korea". J Hepatol. 2024 Feb 01. PMID: 38309438.
      Citations:    Fields:    
    3. Kim D, Perumpail BJ, Cholankeril G, Ahmed A. Association between food insecurity and metabolic dysfunction-associated steatotic liver disease/significant fibrosis measured by fibroscan. Eur J Nutr. 2024 Apr; 63(3):995-1001. PMID: 38260997.
      Citations:    Fields:    Translation:Humans
    4. Benhammou JN, Leng M, Shah SC, Cholankeril G, Dong TS, Patel AA, Tong MJ. Exposure to Agent Orange and Hepatocellular Carcinoma Among US Military Personnel. JAMA Netw Open. 2023 Dec 01; 6(12):e2346380. PMID: 38048128; PMCID: PMC10696483.
      Citations:    Fields:    Translation:Humans
    5. Kim D, Manikat R, Cholankeril G, Ahmed A. Endogenous sex hormones and nonalcoholic fatty liver disease in US adults. Liver Int. 2024 Feb; 44(2):460-471. PMID: 38010926.
      Citations:    Fields:    Translation:Humans
    6. Mathew C, Patel A, Cholankeril G, Flores A, Hernaez R. Using noninvasive clinical parameters to predict mortality and morbidity after cardiac interventions in patients with cirrhosis: A systematic review. Saudi J Gastroenterol. 2024 Jan 01; 30(1):14-22. PMID: 37988070; PMCID: PMC10852145.
      Citations:    Fields:    Translation:Humans
    7. Kanwal F, Nelson R, Liu Y, Kramer JR, Hernaez R, Cholankeril G, Rana A, Flores A, Smith D, Cao Y, Beech B, Asch SM. Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2023 Oct 27. PMID: 37561079.
      Citations:    Fields:    
    8. Bangaru S, Sundaresh R, Lee A, Prause N, Hao F, Dong TS, Tincopa M, Cholankeril G, Rich NE, Kawamoto J, Bhattacharya D, Han SB, Patel AA, Shaheen M, Benhammou JN. Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records. Dig Dis Sci. 2023 12; 68(12):4474-4484. PMID: 37864738; PMCID: PMC10635943.
      Citations:    Fields:    Translation:Humans
    9. Kim D, Manikat R, Wijarnpreecha K, Cholankeril G, Ahmed A. Chronic liver disease-related mortality during the COVID-19 pandemic. Eur J Intern Med. 2023 12; 118:129-132. PMID: 37777423.
      Citations:    Fields:    Translation:HumansPHPublic Health
    10. Cholankeril G, Vierling JM, Cholankeril G, Vierling JM. The clinical imperative of a complete biochemical response to immunosuppression in autoimmune hepatitis: Close is not good enough! Hepatology. 2024 Mar 01; 79(3):529-531. PMID: 37722131.
      Citations:    Fields:    Translation:Humans
    11. Kim D, Wijarnpreecha K, Cholankeril G, Ahmed A. Metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality among adults in the United States. J Hepatol. 2024 Feb; 80(2):e79-e81. PMID: 37717601.
      Citations:    Fields:    Translation:Humans
    12. Kim D, Manikat R, Shaikh A, Cholankeril G, Ahmed A. Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality. Eur J Clin Invest. 2024 Jan; 54(1):e14087. PMID: 37638383.
      Citations:    Fields:    Translation:Humans
    13. Anouti A, Patel MS, VanWagner LB, Lee WM, Fung JJ, Cholankeril G, Hwang CS, Mufti AR, Tujios S, Kerr T, Rich NE, Louissaint J, Desai DM, Vagefi PA, Hanish S, Shah J, Singal AG, Cotter TG. Biliary atresia and liver transplantation in the United States: A contemporary analysis. Liver Int. 2023 10; 43(10):2198-2209. PMID: 37548078.
      Citations:    Fields:    Translation:Humans
    14. Kim D, Manikat R, Cholankeril G, Ahmed A. Trends in mortality of liver cancer before and during the COVID-19 pandemic, 2017-2021. Liver Int. 2023 09; 43(9):1865-1870. PMID: 37387517.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    15. Sacleux SC, Khemichian S, Stein LL, Shetty K, Lindenmeyer CC, Simonetto DA, Rahimi RS, Jalal PK, Kriss MS, Im GY, Jou JH, Fortune BE, Cholankeril G, Kuo A, Mahmud N, Saliba F, Sundaram V, Jalan R, Multi-Organ Dysfunction and Evaluation for Liver Transplantation (MODEL) Consortium, Hernaez R, Karvellas CJ, Liu Y, Boike JR, Izzy M, Lin MV, Kanwal F, Artzner T. The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure. J Hepatol. 2023 09; 79(3):717-727. PMID: 37315809.
      Citations:    Fields:    Translation:Humans
    16. Kim D, Perumpail BJ, Wijarnpreecha K, Manikat R, Cholankeril G, Ahmed A. Trends in aetiology-based hospitalisation for cirrhosis before and during the COVID-19 pandemic in the United States. Aliment Pharmacol Ther. 2023 07; 58(2):218-228. PMID: 37189243.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    17. Rich NE, Shaikh A, Lee TH, Benhammou JN, Lymberopoulos P, Agopian VG, Kim D, Ahmed A, Hernaez R, Berg CL, Goss J, Rana A, Kanwal F, Cholankeril G. Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy. Liver Transpl. 2023 10 01; 29(10):1138-1142. PMID: 37129867; PMCID: PMC10664818.
      Citations:    Fields:    Translation:Humans
    18. Bhatnagar A, Prakash S, Lymberopoulos P, Goff C, Shaikh A, Kim D, Ahmed A, Berg C, Naggie S, Kanwal F, Cholankeril G, Lee TH. Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities. Am J Transplant. 2023 08; 23(8):1221-1226. PMID: 37116583.
      Citations:    Fields:    Translation:HumansCells
    19. Goli K, Lymberopoulos P, Samuel R, Shaikh A, Parakadavil N, Kim D, Ahmed A, Goss JA, Rana A, Lee TH, Kanwal F, Cholankeril G. Posttransplant outcomes for alcohol-associated liver disease during the COVID-19 pandemic. Liver Transpl. 2023 07 01; 29(7):777-780. PMID: 36872590; PMCID: PMC10269682.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    20. Kim D, Wijarnpreecha K, Dennis BB, Cholankeril G, Ahmed A. Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular Mortality. J Clin Med. 2023 Feb 28; 12(5). PMID: 36902707; PMCID: PMC10004264.
      Citations:    
    21. Kim D, Dennis BB, Cholankeril G, Ahmed A. Association between depression and metabolic dysfunction-associated fatty liver disease/significant fibrosis. J Affect Disord. 2023 05 15; 329:184-191. PMID: 36841305.
      Citations:    Fields:    Translation:Humans
    22. Shaikh A, Ahmed A, Kim D, Rana A, Goss JA, Naggie S, Jacob JS, Goli K, Rich NE, Benhammou JN, Lee TH, Kanwal F, Cholankeril G. Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras. Clin Infect Dis. 2023 02 18; 76(4):592-599. PMID: 36221143; PMCID: PMC10169442.
      Citations:    Fields:    Translation:HumansCells
    23. Ganga A, Kim EJ, Mintzer GL, Adriance W, Wang R, Cholankeril G, Balkrishnan R, Somasundar PS. Disparities in primary pancreatic adenocarcinoma survival by Medicaid-status: A national population-based risk analysis. Eur J Surg Oncol. 2023 07; 49(7):1242-1249. PMID: 36801151.
      Citations:    Fields:    Translation:Humans
    24. Muftah AA, Banala C, Raasikh T, Jamali T, Bustamante G, Cholankeril G, Kanwal F, Flores A, Hernaez R. Telehealth interventions in patients with chronic liver diseases: A systematic review. Hepatology. 2023 07 01; 78(1):179-194. PMID: 36632994.
      Citations:    Fields:    Translation:Humans
    25. Kim D, Dennis BB, Wijarnpreecha K, Cholankeril G, Ahmed A. Muscle strength in non-alcoholic fatty liver disease and all-cause and cause-specific mortality. Liver Int. 2023 02; 43(2):513-516. PMID: 36520009.
      Citations: 1     Fields:    Translation:Humans
    26. Shaikh A, Goli K, Lee TH, Benhammou JN, Keeling S, Kim D, Ahmed A, Goss J, Rana A, Kanwal F, Rich NE, Singal AG, Cholankeril G. Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era. Clin Gastroenterol Hepatol. 2023 08; 21(9):2288-2297.e4. PMID: 36521738; PMCID: PMC10686256.
      Citations:    Fields:    Translation:HumansCells
    27. Kim EJ, Ganga A, Lee JY, Zawadzki RS, Adriance W, Wang R, Cholankeril G, Somasundar PS. Disparities in hepatocellular carcinoma survival by Medicaid-status: A national population-based risk analysis. Eur J Surg Oncol. 2023 04; 49(4):794-801. PMID: 36503726.
      Citations:    Fields:    Translation:Humans
    28. Cholankeril G, Kramer JR, Chu J, Yu X, Balakrishnan M, Li L, El-Serag HB, Kanwal F. Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease. J Hepatol. 2023 03; 78(3):493-500. PMID: 36402450; PMCID: PMC10661838.
      Citations: 6     Fields:    Translation:Humans
    29. Oden-Brunson H, McDonald MF, Godfrey E, Keeling SS, Kanwal F, Cholankeril G, O'Mahony C, Goss J, Rana A. Is Liver Transplant Justified at Any MELD Score? Transplantation. 2023 03 01; 107(3):680-692. PMID: 36367923.
      Citations:    Fields:    Translation:Humans
    30. Cholankeril G, El-Serag HB. Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Semin Liver Dis. 2023 02; 43(1):89-99. PMID: 36216350.
      Citations: 1     Fields:    Translation:Humans
    31. Kim D, Alshuwaykh O, Dennis BB, Cholankeril G, Knowles JW, Ahmed A. Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States. Dig Liver Dis. 2023 01; 55(1):3-10. PMID: 36182570; PMCID: PMC9534558.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    32. Kim D, Perumpail BJ, Alshuwaykh O, Dennis BB, Cholankeril G, Ahmed A. Changing trends in aetiology-based hospitalizations with end-stage liver disease in the United States from 2016 to 2019. Liver Int. 2022 11; 42(11):2390-2395. PMID: 35906461.
      Citations:    Fields:    
    33. Goff C, Shaikh A, Goli K, El-Serag HB, Kanwal F, Cholankeril G, Liver Cancer Investigator Working Group. Contemporary Changes in Etiology for Hepatocellular Carcinoma in Liver Transplantation. Clin Gastroenterol Hepatol. 2023 08; 21(9):2410-2412.e1. PMID: 35870770; PMCID: PMC10601142.
      Citations:    Fields:    
    34. Keeling SS, McDonald MF, Anand A, Goff CR, Christmann CR, Barrett SC, Kueht M, Goss JA, Cholankeril G, Rana A. Do Patients with Autoimmune Conditions Have Less Access to Liver Transplantation despite Superior Outcomes? J Pers Med. 2022 Jul 17; 12(7). PMID: 35887656; PMCID: PMC9320508.
      Citations:    
    35. Kim D, Alshuwaykh O, Dennis BB, Cholankeril G, Ahmed A. Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States. Clin Gastroenterol Hepatol. 2022 10; 20(10):2307-2316.e3. PMID: 35811045; PMCID: PMC9262655.
      Citations:    Fields:    
    36. Chu J, Cholankeril G, Yu X, Rana A, Natarajan Y, El-Serag HB, Kramer J, Kanwal F. Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC). Dig Dis Sci. 2023 03; 68(3):1060-1070. PMID: 35759159; PMCID: PMC9792631.
      Citations:    Fields:    
    37. Kim D, Alshuwaykh O, Sandhu KK, Dennis BB, Cholankeril G, Ahmed A. Trends in All-Cause and Cause-Specific Mortality Among Individuals With Diabetes Before and During the COVID-19 Pandemic in the U.S. Diabetes Care. 2022 06 02; 45(6):e107-e109. PMID: 35446372.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    38. Konyn P, Alshuwaykh O, Dennis BB, Cholankeril G, Ahmed A, Kim D. Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality. Clin Gastroenterol Hepatol. 2023 04; 21(4):940-948.e2. PMID: 35643414.
      Citations:    Fields:    
    39. Shaikh A, Goli K, Rich NE, Benhammou JN, Khaderi S, Hernaez R, Agopian VG, Vierling JM, Kim D, Ahmed A, Goss JA, Rana A, Kanwal F, Cholankeril G. Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma. Transplant Direct. 2022 May; 8(5):e1313. PMID: 35434283; PMCID: PMC9005245.
      Citations:    
    40. Lymberopoulos P, Shaikh A, Rich NE, Benhammou JN, Kanwal F, Cholankeril G. Comparable Survival for Hepatitis C-Related Hepatocellular Carcinoma After Liver Transplantation Irrespective of Viremic Status. Clin Gastroenterol Hepatol. 2023 05; 21(5):1362-1364.e1. PMID: 35346850; PMCID: PMC10236899.
      Citations:    Fields:    
    41. Keeling SS, McDonald MF, Anand A, Handing GE, Prather LL, Christmann CR, Jalal PK, Kanwal F, Cholankeril G, Goss JA, Rana A. Significant improvements, but consistent disparities in survival for African Americans after liver transplantation. Clin Transplant. 2022 06; 36(6):e14646. PMID: 35304775; PMCID: PMC9310351.
      Citations:    Fields:    Translation:Humans
    42. Benhammou JN, Rich NE, Cholankeril G, Zhang P, Zeng W, Rao S, Tayob N, National Cancer Institute?s Translational Liver Consortium Early-Career Working Group. DETECT: Development of Technologies for Early HCC Detection. Gastroenterology. 2022 07; 163(1):21-27. PMID: 35339460; PMCID: PMC9232964.
      Citations:    Fields:    Translation:Humans
    43. Goff C, Zhang T, McDonald M, Anand A, Galvan NTN, Kanwal F, Cholankeril G, Hernaez R, Goss JA, Rana A. Marginal allografts in liver transplantation have a limited impact on length of stay. Clin Transplant. 2022 03; 36(3):e14544. PMID: 34854503.
      Citations:    Fields:    Translation:Humans
    44. Cholankeril G, Al-Hillan A, Tarlow B, Abrams D, Jacobs JS, Flores NP, Rana A, Kanwal F, Goss JA. Clinical Factors Associated With Lack of Serological Response to SARS-CoV-2 Messenger RNA Vaccine in Liver Transplantation Recipients. Liver Transpl. 2022 01; 28(1):123-126. PMID: 34724328; PMCID: PMC8661604.
      Citations: 3     Fields:    Translation:HumansCells
    45. Kim D, Cholankeril G, Dennis BB, Alshuwaykh O, Kumari R, Wong RJ, Ahmed A. Trends in the Prevalence of Hepatitis C Virus Infection based on the Insurance Status in the United States from 2013 to 2018. Liver Int. 2022 02; 42(2):340-349. PMID: 34817925.
      Citations:    Fields:    Translation:HumansCells
    46. Dennis BB, Martin LJ, Naji L, Akhtar D, Cholankeril G, Kim D, Sanger N, Hillmer A, Chawar C, D'Elia A, Panesar B, Worster A, Marsh DC, O'Shea T, Bawor M, Thabane L, Samaan Z, Ahmed A. Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis. J Addict Med. 2022 Jul-Aug 01; 16(4):e248-e256. PMID: 34799492.
      Citations:    Fields:    
    47. Kulkarni C, Murag S, Cholankeril G, Fardeen T, Mannalithara A, Lerrigo R, Kamal A, Ahmed A, Goel A, Sinha SR. Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing Cholangitis. Inflamm Bowel Dis. 2021 10 18; 27(10):1602-1609. PMID: 33300561.
      Citations:    Fields:    Translation:Humans
    48. Jacob JS, Ahmed A, Cholankeril G. The impact of alteration in gut microbiome in the pathogenesis of nonalcoholic fatty liver disease. Curr Opin Infect Dis. 2021 10 01; 34(5):477-482. PMID: 34267042.
      Citations: 2     Fields:    Translation:HumansAnimals
    49. Dennis BB, Sallam S, Perumpail BJ, Shah ND, Kim D, Cholankeril G, Ahmed A. Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease: A Review of the Literature With Recommendations. J Clin Gastroenterol. 2021 10 01; 55(9):747-756. PMID: 34469404.
      Citations: 2     Fields:    Translation:Humans
    50. Joshi T, Ahmed A, Cholankeril G. Gastrointestinal manifestations of coronavirus disease 2019. Curr Opin Infect Dis. 2021 10 01; 34(5):471-476. PMID: 34524198.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    51. Cholankeril G, Goli K, Rana A, Hernaez R, Podboy A, Jalal P, Da BL, Satapathy SK, Kim D, Ahmed A, Goss J, Kanwal F. Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology. 2021 12; 74(6):3316-3329. PMID: 34310738; PMCID: PMC8426752.
      Citations: 4     Fields:    Translation:HumansCells
    52. Joshi T, Rana A, Vierling JM, Kanwal F, Goss JA, Cholankeril G. Practical Consideration for Drug Monitoring of Tacrolimus in Liver Transplantation Recipients with SARS-CoV-2 Infection. Liver Transpl. 2022 01; 28(1):127-130. PMID: 34416083; PMCID: PMC8662081.
      Citations:    Fields:    Translation:HumansCells
    53. McDonald MF, Barrett SC, Malik TH, Anand A, Keeling SS, Christmann CR, Goff CR, Galvan T, Cholankeril G, Goss J, Rana A, Kanwal F. Elevated serum sodium in recipients of liver transplantation has a substantial impact on outcomes. Transpl Int. 2021 Oct; 34(10):1971-1983. PMID: 34218471.
      Citations:    Fields:    Translation:Humans
    54. Cholankeril G, Kanwal F. NAFLD and HCC: Time to Bridge the Gap. Hepatology. 2021 11; 74(5):2336-2338. PMID: 34164841; PMCID: PMC9277557.
      Citations:    Fields:    Translation:Humans
    55. Kim D, Bonham CA, Konyn P, Cholankeril G, Ahmed A. Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic. Clin Gastroenterol Hepatol. 2021 12; 19(12):2664-2666.e2. PMID: 34256143; PMCID: PMC8271030.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    56. Kim D, Konyn P, Cholankeril G, Ahmed A. Physical Activity Is Associated With Nonalcoholic Fatty Liver Disease and Significant Fibrosis Measured by FibroScan. Clin Gastroenterol Hepatol. 2022 06; 20(6):e1438-e1455. PMID: 34214678.
      Citations: 3     Fields:    Translation:Humans
    57. Bhatti S, Kim D, Ahmed A, Cholankeril G. Current Trends in Liver Transplantation for Alcoholic Hepatitis. Clin Liver Dis. 2021 08; 25(3):625-634. PMID: 34229844.
      Citations:    Fields:    Translation:Humans
    58. Kim D, Konyn P, Cholankeril G, Bonham CA, Ahmed A. Trends in the Mortality of Biliary Tract Cancers Based on Their Anatomical Site in the United States From 2009 to 2018. Am J Gastroenterol. 2021 05 01; 116(5):1053-1062. PMID: 33929380.
      Citations: 1     Fields:    Translation:Humans
    59. Kim D, Wijarnpreecha K, Sandhu KK, Cholankeril G, Ahmed A. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States. Liver Int. 2021 08; 41(8):1832-1840. PMID: 33641244.
      Citations: 4     Fields:    Translation:Humans
    60. Kim D, Cholankeril G, Loomba R, Ahmed A. Prevalence of Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis Among US Adults with Prediabetes and Diabetes, NHANES 2017-2018. J Gen Intern Med. 2022 01; 37(1):261-263. PMID: 33674915; PMCID: PMC8738798.
      Citations: 3     Fields:    Translation:Humans
    61. Kim D, Alshuwaykh OS, Cholankeril G, Wong RJ, Ahmed A. Trends in mortality in hepatitis C infection and alcoholic liver disease based on drug overdose in the United States. J Viral Hepat. 2021 02; 28(2):436-439. PMID: 33147365.
      Citations:    Fields:    Translation:HumansCells
    62. Barakat MT, Cholankeril G, Gugig R, Berquist WE. Nationwide Evolution of Pediatric Endoscopic Retrograde Cholangiopancreatography Indications, Utilization, and Readmissions over?Time. J Pediatr. 2021 05; 232:159-165.e1. PMID: 33197494.
      Citations: 3     Fields:    Translation:Humans
    63. Tarlow B, Gubatan J, Khan MA, Cholankeril G. Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection? Am J Gastroenterol. 2020 11; 115(11):1920-1921. PMID: 33156116; PMCID: PMC7505035.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    64. Cholankeril G, Podboy A, Alshuwaykh OS, Kim D, Kanwal F, Esquivel CO, Ahmed A. Early Impact of COVID-19 on Solid Organ Transplantation in the United States. Transplantation. 2020 11; 104(11):2221-2224. PMID: 32675741; PMCID: PMC7406203.
      Citations: 21     Fields:    Translation:HumansCellsPHPublic Health
    65. Kim D, Vazquez-Montesino LM, Li AA, Cholankeril G, Ahmed A. Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease. Hepatology. 2020 11; 72(5):1556-1568. PMID: 32012316.
      Citations: 16     Fields:    Translation:Humans
    66. Kim D, Vazquez-Montesino LM, Escober JA, Fernandes CT, Cholankeril G, Loomba R, Harrison SA, Younossi ZM, Ahmed A. Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality. Am J Gastroenterol. 2020 09; 115(9):1496-1504. PMID: 32496342.
      Citations: 10     Fields:    Translation:Humans
    67. Kim D, Cholankeril G, Loomba R, Ahmed A. Prevalence of Fatty Liver Disease and Fibrosis Detected by Transient Elastography in Adults in the United States, 2017-2018. Clin Gastroenterol Hepatol. 2021 07; 19(7):1499-1501.e2. PMID: 32801011.
      Citations: 7     Fields:    Translation:Humans
    68. Kim D, Murag S, Cholankeril G, Cheung A, Harrison SA, Younossi ZM, Ahmed A. Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2021 06; 19(6):1240-1247.e5. PMID: 32683103.
      Citations: 8     Fields:    Translation:Humans
    69. Cholankeril G, Podboy A, Aivaliotis VI, Pham EA, Spencer SP, Kim D, Ahmed A. Association of Digestive Symptoms and Hospitalization in Patients With SARS-CoV-2 Infection. Am J Gastroenterol. 2020 07; 115(7):1129-1132. PMID: 32618665; PMCID: PMC7302101.
      Citations: 23     Fields:    Translation:HumansCellsPHPublic Health
    70. Podboy A, Cholankeril G, Cianfichi L, Guzman E, Ahmed A, Banerjee S. Implementation and Impact of Universal Preprocedure Testing of Patients for COVID-19 Before Endoscopy. Gastroenterology. 2020 Oct; 159(4):1586-1588.e4. PMID: 32562723; PMCID: PMC7833582.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    71. Adejumo AC, Akhtar DH, Dennis BB, Cholankeril G, Alayo Q, Ogundipe OA, Kim D, Ahmed A. Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA. Dig Dis Sci. 2021 05; 66(5):1461-1476. PMID: 32535779.
      Citations: 1     Fields:    Translation:Humans
    72. Kim D, Konyn P, Cholankeril G, Wong RJ, Younossi ZM, Ahmed A, Hepatocellular Carcinoma Research Committee for Chronic Liver Disease Foundation. Decline in Annual Mortality of Hepatitis C Virus-Related Hepatocellular Carcinoma in the United States, From 2009 to 2018. Gastroenterology. 2020 10; 159(4):1558-1560.e2. PMID: 32389664.
      Citations:    Fields:    Translation:Humans
    73. Cholankeril G, Podboy A, Aivaliotas V, Pham EA, Tarlow B, Spencer S, Kim D, Hsing A, Ahmed A. Association of Digestive Symptoms and Hospitalization in Patients with SARS-CoV-2 Infection. medRxiv. 2020 Apr 28. PMID: 32511634; PMCID: PMC7276990.
      Citations: 3     
    74. Cholankeril G, Podboy A, Aivaliotis VI, Tarlow B, Pham EA, Spencer SP, Kim D, Hsing A, Ahmed A. High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience From California. Gastroenterology. 2020 08; 159(2):775-777. PMID: 32283101; PMCID: PMC7194555.
      Citations: 100     Fields:    Translation:HumansCellsPHPublic Health
    75. Marella HK, Reddy YK, Jiang Y, Ganguli S, Podila PSB, Snell PD, Kovalic AJ, Cholankeril G, Singal AK, Nair S, Maliakkal B, Satapathy SK. Accuracy of Noninvasive Fibrosis Scoring Systems in African American and White Patients With Nonalcoholic Fatty Liver Disease. Clin Transl Gastroenterol. 2020 04; 11(4):e00165. PMID: 32352687; PMCID: PMC7263664.
      Citations: 1     Fields:    Translation:Humans
    76. Yoo ER, Cholankeril G, Ahmed A. Treating Alcohol Use Disorder in Chronic Liver Disease. Clin Liver Dis (Hoboken). 2020 Feb; 15(2):77-80. PMID: 32226621; PMCID: PMC7098671.
      Citations:    
    77. Kim D, Yoo ER, Li AA, Tighe SP, Cholankeril G, Ahmed A. Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014. Dig Dis Sci. 2021 01; 66(1):296-307. PMID: 32124196.
      Citations: 3     Fields:    Translation:HumansCells
    78. Dennis BB, Akhtar D, Cholankeril G, Kim D, Sanger N, Hillmer A, Chawar C, D'Elia A, Panesar B, Worster A, Marsh DC, Thabane L, Samaan Z, Ahmed A. The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study. Drug Alcohol Depend. 2020 04 01; 209:107917. PMID: 32088589.
      Citations: 4     Fields:    Translation:Humans
    79. Yoo ER, Kim D, Vazquez-Montesino LM, Escober JA, Li AA, Tighe SP, Fernandes CT, Cholankeril G, Ahmed A. Diet quality and its association with nonalcoholic fatty liver disease and all-cause and cause-specific mortality. Liver Int. 2020 04; 40(4):815-824. PMID: 31910319.
      Citations: 4     Fields:    Translation:Humans
    80. Murag S, Dennis BB, Kim D, Ahmed A, Cholankeril G. Recent advances in liver transplantation with HCV seropositive donors. F1000Res. 2019; 8. PMID: 31942236; PMCID: PMC6944251.
      Citations:    Fields:    Translation:HumansCells
    81. Cholankeril G, Dennis BB, Kim D, Ahmed A. Regional Trends in Mortality from Alcohol-Induced Causes in the United States, 2000-2017. J Gen Intern Med. 2020 08; 35(8):2495-2498. PMID: 31792862; PMCID: PMC7403270.
      Citations: 1     Fields:    Translation:Humans
    82. Kovalic AJ, Cholankeril G, Satapathy SK. Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations. Transl Gastroenterol Hepatol. 2019; 4:65. PMID: 31620647; PMCID: PMC6789306.
      Citations: 8     
    83. Adejumo AC, Kim D, Iqbal U, Yoo ER, Boursiquot BC, Cholankeril G, Wong RJ, Kwo PY, Ahmed A. Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease. J Palliat Med. 2020 01; 23(1):97-106. PMID: 31397615; PMCID: PMC6931914.
      Citations: 3     Fields:    Translation:Humans
    84. Adejumo AC, Cholankeril G, Iqbal U, Yoo ER, Boursiquot BC, Concepcion WC, Kim D, Ahmed A. Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study. Dig Dis Sci. 2020 04; 65(4):990-1002. PMID: 31372912.
      Citations: 6     Fields:    Translation:Humans
    85. Kim D, Yoo ER, Li AA, Tighe SP, Cholankeril G, Harrison SA, Ahmed A. Depression is associated with non-alcoholic fatty liver disease among adults in the United States. Aliment Pharmacol Ther. 2019 09; 50(5):590-598. PMID: 31328300.
      Citations: 16     Fields:    Translation:Humans
    86. Kim D, Adejumo AC, Yoo ER, Iqbal U, Li AA, Pham EA, Cholankeril G, Glenn JS, Ahmed A. Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017. Gastroenterology. 2019 10; 157(4):1055-1066.e11. PMID: 31251928.
      Citations: 13     Fields:    Translation:Humans
    87. Kim D, Cholankeril G, Kim SH, Abbasi F, Knowles JW, Ahmed A. Increasing Mortality Among Patients With Diabetes and Chronic Liver Disease From 2007 to 2017. Clin Gastroenterol Hepatol. 2020 04; 18(4):992-994. PMID: 31220638; PMCID: PMC7064319.
      Citations: 1     Fields:    Translation:Humans
    88. Cholankeril G, Li AA, Dennis BB, Gadiparthi C, Kim D, Toll AE, Maliakkal BJ, Satapathy SK, Nair S, Ahmed A. Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation. Sci Rep. 2019 06 05; 9(1):8312. PMID: 31165776; PMCID: PMC6549161.
      Citations: 1     Fields:    Translation:Humans
    89. Kim D, Cholankeril G, Li AA, Kim W, Tighe SP, Hameed B, Kwo PY, Harrison SA, Younossi ZM, Ahmed A. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014. Liver Int. 2019 09; 39(9):1661-1671. PMID: 31081997.
      Citations: 16     Fields:    Translation:Humans
    90. Gadiparthi C, Yoo ER, Are VS, Charilaou P, Kim D, Cholankeril G, Pitchumoni C, Ahmed A. Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers. Ann Hepatol. 2019 Sep - Oct; 18(5):679-684. PMID: 31164267.
      Citations: 1     Fields:    Translation:Humans
    91. Dibba P, Li AA, Cholankeril G, Ali Khan M, Kim D, Ahmed A. Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary. Nutr Metab Insights. 2019; 12:1178638819847480. PMID: 31308686; PMCID: PMC6612909.
      Citations: 1     
    92. Kim D, Li AA, Cholankeril G, Kim SH, Ingelsson E, Knowles JW, Harrington RA, Ahmed A. Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017. Diabetologia. 2019 07; 62(7):1185-1194. PMID: 31011776; PMCID: PMC7063897.
      Citations: 5     Fields:    Translation:Humans
    93. Kim D, Yoo ER, Li AA, Cholankeril G, Tighe SP, Kim W, Harrison SA, Ahmed A. Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States. Liver Int. 2019 07; 39(7):1335-1342. PMID: 30924602.
      Citations: 11     Fields:    Translation:Humans
    94. Molnar MZ, Joglekar K, Jiang Y, Cholankeril G, Abdul MKM, Kedia S, Gonzalez HC, Ahmed A, Singal A, Bhamidimarri KR, Aithal GP, Duseja A, Wong VW, Gulnare A, Puri P, Nair S, Eason JD, Satapathy SK, Global NAFLD Consortium. Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis. Liver Transpl. 2019 03; 25(3):399-410. PMID: 30369023; PMCID: PMC6709989.
      Citations: 10     Fields:    Translation:Humans
    95. Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD. Diseases. 2019 Feb 25; 7(1). PMID: 30823570; PMCID: PMC6473757.
      Citations: 14     
    96. Kim D, Li AA, Perumpail BJ, Gadiparthi C, Kim W, Cholankeril G, Glenn JS, Harrison SA, Younossi ZM, Ahmed A. Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States. Hepatology. 2019 03; 69(3):1064-1074. PMID: 30014489; PMCID: PMC6709988.
      Citations: 57     Fields:    Translation:Humans
    97. Cholankeril G, Hu M, Cholankeril R, Khan MA, Gadiparthi C, Yoo ER, Perumpail RB, Nair S, Howden CW. Inpatient Outcomes for Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention. J Clin Gastroenterol. 2019 02; 53(2):120-126. PMID: 29351155.
      Citations: 1     Fields:    Translation:Humans
    98. Farooqui MT, Khan MA, Cholankeril G, Khan Z, Mohammed Abdul MK, Li AA, Shah N, Wu L, Haq K, Solanki S, Kim D, Ahmed A. Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2019 02; 31(2):149-156. PMID: 30234644; PMCID: PMC6467701.
      Citations: 3     Fields:    Translation:Humans
    99. Kim D, Kim W, Adejumo AC, Cholankeril G, Tighe SP, Wong RJ, Gonzalez SA, Harrison SA, Younossi ZM, Ahmed A. Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016. Hepatol Int. 2019 Mar; 13(2):205-213. PMID: 30694445.
      Citations: 15     Fields:    Translation:Humans
    100. Li AA, Cholankeril G, Berry GJ, Fernandez-Becker N. An Unexpected Colonic Mass. Am J Gastroenterol. 2019 01; 114(1):180-181. PMID: 30333533; PMCID: PMC6467712.
      Citations:    Fields:    Translation:HumansAnimals
    101. Cholankeril G, Gadiparthi C, Yoo ER, Dennis BB, Li AA, Hu M, Wong K, Kim D, Ahmed A. Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United States. Transplantation. 2019 01; 103(1):131-139. PMID: 30300285; PMCID: PMC6709987.
      Citations: 6     Fields:    Translation:Humans
    102. Iqbal U, Dennis BB, Li AA, Cholankeril G, Kim D, Khan MA, Ahmed A. Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis. Hepatol Int. 2019 Jan; 13(1):84-90. PMID: 30539518; PMCID: PMC6675411.
      Citations: 10     Fields:    Translation:Humans
    103. Kim D, Yoo ER, Li AA, Fernandes CT, Tighe SP, Cholankeril G, Hameed B, Ahmed A. Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States. Clin Gastroenterol Hepatol. 2019 10; 17(11):2379-2381. PMID: 30458247; PMCID: PMC6525074.
      Citations: 14     Fields:    Translation:Humans
    104. Kim D, Li AA, Perumpail RB, Cholankeril G, Gonzalez SA, Kim W, Ahmed A. Disparate Trends in Mortality of Etiology-Specific Chronic Liver Diseases Among Hispanic Subpopulations. Clin Gastroenterol Hepatol. 2019 07; 17(8):1607-1615.e2. PMID: 30391436; PMCID: PMC6675399.
      Citations: 8     Fields:    Translation:Humans
    105. Puri P, Cholankeril G, Myint TY, Goel A, Sarin SK, Harper AM, Ahmed A. Early Liver Transplantation is a Viable Treatment Option in Severe Acute Alcoholic Hepatitis. Alcohol Alcohol. 2018 Nov 01; 53(6):716-718. PMID: 30099535; PMCID: PMC6203122.
      Citations: 6     Fields:    Translation:Humans
    106. Yoo ER, Sallam S, Perumpail BJ, Iqbal U, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. When to Initiate Weight Loss Medications in the NAFLD Population. Diseases. 2018 Sep 30; 6(4). PMID: 30274326; PMCID: PMC6313489.
      Citations: 4     
    107. Cholankeril G, Li AA, Dennis BB, Toll AE, Kim D, Bonham CA, Nair S, Ahmed A. Increasing Trends in Transplantation of HCV-Positive Livers Into Uninfected Recipients. Clin Gastroenterol Hepatol. 2019 07; 17(8):1634-1636. PMID: 30268562; PMCID: PMC6470034.
      Citations: 4     Fields:    Translation:HumansCells
    108. Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. The Role of Vitamin E in the Treatment of NAFLD. Diseases. 2018 Sep 24; 6(4). PMID: 30249972; PMCID: PMC6313719.
      Citations: 20     
    109. Iqbal U, Perumpail BJ, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Judicious Use of Lipid Lowering Agents in the Management of NAFLD. Diseases. 2018 Sep 24; 6(4). PMID: 30249980; PMCID: PMC6313319.
      Citations: 6     
    110. Dibba P, Li AA, Perumpail BJ, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD. Diseases. 2018 Sep 19; 6(3). PMID: 30235807; PMCID: PMC6164020.
      Citations: 5     
    111. Li AA, Kim D, Kim W, Dibba P, Wong K, Cholankeril G, Jacobson IM, Younossi ZM, Ahmed A. Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016. J Viral Hepat. 2018 12; 25(12):1608-1616. PMID: 30112849; PMCID: PMC6709979.
      Citations: 4     Fields:    Translation:Humans
    112. Perumpail BJ, Li AA, Iqbal U, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD. Diseases. 2018 Sep 10; 6(3). PMID: 30201879; PMCID: PMC6165515.
      Citations: 10     
    113. Cholankeril G, Li AA, Cholankeril R, Toll AE, Glenn JS, Ahmed A. Impact of Drug Overdose Deaths on Solid Organ Transplantation in the United States. J Gen Intern Med. 2018 09; 33(9):1423-1425. PMID: 29766381; PMCID: PMC6109002.
      Citations: 1     Fields:    Translation:Humans
    114. Kim D, Li AA, Gadiparthi C, Khan MA, Cholankeril G, Glenn JS, Ahmed A. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016. Gastroenterology. 2018 10; 155(4):1154-1163.e3. PMID: 30009816; PMCID: PMC6467699.
      Citations: 61     Fields:    Translation:Humans
    115. Cholankeril G, Gadiparthi C, Kim D, Ahmed A. Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients. Hepatology. 2018 08; 68(2):792-793. PMID: 29672899; PMCID: PMC6675396.
      Citations:    Fields:    Translation:HumansCells
    116. Liu A, Galoosian A, Kaswala D, Li AA, Gadiparthi C, Cholankeril G, Kim D, Ahmed A. Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft. J Clin Transl Hepatol. 2018 Dec 28; 6(4):420-424. PMID: 30637220; PMCID: PMC6328728.
      Citations: 9     
    117. Li AA, Cholankeril G, Cheng XS, Tan JC, Kim D, Toll AE, Nair S, Ahmed A. Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era. Diseases. 2018 Jul 10; 6(3). PMID: 29996536; PMCID: PMC6165210.
      Citations: 4     
    118. Dibba P, Li AA, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A. The Role of Cannabinoids in the Setting of Cirrhosis. Medicines (Basel). 2018 Jun 09; 5(2). PMID: 29890719; PMCID: PMC6023500.
      Citations: 10     
    119. Dibba P, Li A, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A. Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease. Medicines (Basel). 2018 May 28; 5(2). PMID: 29843404; PMCID: PMC6023518.
      Citations: 8     
    120. Li AA, Dibba P, Cholankeril G, Kim D, Ahmed A. Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver Transplantation. Diseases. 2018 May 19; 6(2). PMID: 29783726; PMCID: PMC6023516.
      Citations: 1     
    121. Gadiparthi C, Cholankeril G, Yoo ER, Hu M, Wong RJ, Ahmed A. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy. Dig Dis Sci. 2018 Jun; 63(6):1647-1653. PMID: 29611079.
      Citations: 2     Fields:    Translation:Humans
    122. Snyder HS, Sakaan SA, March KL, Siddique O, Cholankeril R, Cummings CD, Gadiparthi C, Satapathy SK, Ahmed A, Cholankeril G. Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies. J Clin Transl Hepatol. 2018 Jun 28; 6(2):168-174. PMID: 29951362; PMCID: PMC6018310.
      Citations: 13     
    123. Cholankeril G, Gonzalez HC, Satapathy SK, Gonzalez SA, Hu M, Khan MA, Yoo ER, Li AA, Kim D, Nair S, Wong RJ, Kwo PY, Harrison SA, Younossi ZM, Lindor KD, Ahmed A. Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2018 06; 16(6):965-973.e2. PMID: 29427734; PMCID: PMC7331901.
      Citations: 11     Fields:    Translation:Humans
    124. Gadiparthi C, Cholankeril G, Perumpail BJ, Yoo ER, Satapathy SK, Nair S, Ahmed A. Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates. World J Gastroenterol. 2018 Jan 21; 24(3):315-322. PMID: 29391754; PMCID: PMC5776393.
      Citations: 7     Fields:    Translation:HumansCells
    125. Perumpail BJ, Khan MA, Yoo ER, Cholankeril G, Kim D, Ahmed A. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J Gastroenterol. 2017 Dec 21; 23(47):8263-8276. PMID: 29307986; PMCID: PMC5743497.
      Citations: 194     Fields:    Translation:Humans
    126. Cholankeril G, Li AA, Yoo ER, Ahmed A. Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients. Transplantation. 2017 12; 101(12):e349. PMID: 28846556.
      Citations: 1     Fields:    Translation:Humans
    127. Cholankeril G, Ahmed A. Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as?the Leading Indication for Liver Transplantation in the United?States. Clin Gastroenterol Hepatol. 2018 08; 16(8):1356-1358. PMID: 29199144; PMCID: PMC6467713.
      Citations: 74     Fields:    Translation:Humans
    128. Perumpail BJ, Li AA, Cholankeril G, Kumari R, Ahmed A. Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis. Nutrients. 2017 Oct 13; 9(10). PMID: 29027963; PMCID: PMC5691730.
      Citations: 5     Fields:    Translation:Humans
    129. Kamal F, Khan MA, Khan Z, Cholankeril G, Hammad TA, Lee WM, Ahmed A, Waters B, Howden CW, Nair S, Satapathy SK. Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017 Oct; 29(10):1109-1117. PMID: 28763340.
      Citations: 4     Fields:    Translation:Humans
    130. Cholankeril G, Yoo ER, Perumpail RB, Liu A, Sandhu JS, Nair S, Hu M, Ahmed A. Rising Rates of Hepatocellular Carcinoma Leading to Liver Transplantation in Baby Boomer Generation with Chronic Hepatitis C, Alcohol Liver Disease, and Nonalcoholic Steatohepatitis-Related Liver Disease. Diseases. 2017 Sep 26; 5(4). PMID: 28954412; PMCID: PMC5750531.
      Citations: 3     
    131. Cholankeril G, Joseph-Talreja M, Perumpail BJ, Liu A, Yoo ER, Ahmed A, Goel A. Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents. J Clin Transl Hepatol. 2017 Dec 28; 5(4):363-367. PMID: 29226102; PMCID: PMC5719193.
      Citations: 5     
    132. Cholankeril G, Li AA, March KL, Yoo ER, Kim D, Snyder H, Gonzalez SA, Younossi ZM, Ahmed A. Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral Agents. Clin Gastroenterol Hepatol. 2018 03; 16(3):452-453. PMID: 28838786.
      Citations: 16     Fields:    Translation:HumansPHPublic Health
    133. Cholankeril G, Yoo ER, Hu M, Gadiparthi C, Khan MA, Perumpail RB, Bonham CA, Ahmed A. Rates of liver retransplantation in the United States are declining in the era of direct-acting antiviral agents. J Viral Hepat. 2017 12; 24(12):1194-1195. PMID: 28685914.
      Citations: 1     Fields:    Translation:Humans
    134. Cholankeril G, Wong RJ, Kim D, Ahmed A. Optimal timing for hepatitis C antiviral therapy in the peritransplant period? Hepatology. 2017 09; 66(3):1004. PMID: 28586088.
      Citations:    Fields:    Translation:HumansCells
    135. Cholankeril G, Wong RJ, Hu M, Perumpail RB, Yoo ER, Puri P, Younossi ZM, Harrison SA, Ahmed A. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes. Dig Dis Sci. 2017 10; 62(10):2915-2922. PMID: 28744836.
      Citations: 74     Fields:    Translation:Humans
    136. Kamal S, Khan MA, Seth A, Cholankeril G, Gupta D, Singh U, Kamal F, Howden CW, Stave C, Nair S, Satapathy SK, Ahmed A. Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2017 Oct; 112(10):1495-1505. PMID: 28585556.
      Citations: 33     Fields:    Translation:Humans
    137. Siddique O, Joseph-Talreja M, Yoo ER, Perumpail RB, Cholankeril G, Harrison SA, Younossi ZM, Wong RJ, Ahmed A. Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States. J Clin Transl Hepatol. 2017 Sep 28; 5(3):193-196. PMID: 28936399; PMCID: PMC5606964.
      Citations: 4     
    138. Copelin E, Cholankeril R, Somasundar P, Cholankeril G. Portomesenteric venous thrombosis complicated by a haemorrhagic shock: a rare complication of laparoscopic gastrectomy. BMJ Case Rep. 2017 May 29; 2017. PMID: 28554887; PMCID: PMC5747676.
      Citations:    Fields:    Translation:Humans
    139. Ahmed A, Gonzalez SA, Cholankeril G, Perumpail RB, McGinnis J, Saab S, Beckerman R, Younossi ZM. Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States. Hepatology. 2017 07; 66(1):46-56. PMID: 28257591.
      Citations: 13     Fields:    Translation:Humans
    140. Khan MA, Cholankeril G, Howden CW. Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding? Gastroenterology. 2017 06; 152(8):2076. PMID: 28478154.
      Citations: 4     Fields:    Translation:Humans
    141. Cholankeril G, Patel R, Khurana S, Satapathy SK. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. World J Hepatol. 2017 Apr 18; 9(11):533-543. PMID: 28469809; PMCID: PMC5395802.
      Citations: 58     
    142. Yoo ER, Perumpail RB, Cholankeril G, Jayasekera CR, Ahmed A. The Role of e-Health in Optimizing Task-Shifting in the Delivery of Antiviral Therapy for Chronic Hepatitis C. Telemed J E Health. 2017 10; 23(10):870-873. PMID: 28375820.
      Citations: 2     Fields:    Translation:Humans
    143. Yoo ER, Perumpail RB, Cholankeril G, Jayasekera CR, Ahmed A. Expanding Treatment Access for Chronic Hepatitis C with Task-shifting in the Era of Direct-acting Antivirals. J Clin Transl Hepatol. 2017 Jun 28; 5(2):130-133. PMID: 28660150; PMCID: PMC5472933.
      Citations: 7     
    144. Liu A, Yoo ER, Siddique O, Perumpail RB, Cholankeril G, Ahmed A. Hepatic encephalopathy: what the multidisciplinary team can do. J Multidiscip Healthc. 2017; 10:113-119. PMID: 28392702; PMCID: PMC5373836.
      Citations: 3     
    145. Siddique O, Yoo ER, Perumpail RB, Perumpail BJ, Liu A, Cholankeril G, Ahmed A. The importance of a multidisciplinary approach to hepatocellular carcinoma. J Multidiscip Healthc. 2017; 10:95-100. PMID: 28360525; PMCID: PMC5365324.
      Citations: 16     
    146. Aggarwal A, Yoo ER, Perumpail RB, Cholankeril G, Kumari R, Daugherty TJ, Lapasaran AS, Ahmed A. Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience. J Clin Transl Hepatol. 2017 Mar 28; 5(1):23-26. PMID: 28507922; PMCID: PMC5411352.
      Citations: 5     
    147. Yoo ER, Perumpail RB, Cholankeril G, Ahmed A. Indications for antiviral therapy for chronic hepatitis B in pregnant mothers. BMJ Case Rep. 2016 Nov 15; 2016. PMID: 27852658; PMCID: PMC5128884.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    148. Khan MA, Cholankeril G, Howden CW. Are proton pump inhibitors a threat for spontaneous bacterial peritonitis and hepatic encephalopathy in cirrhosis? Not so fast. Hepatology. 2017 01; 65(1):393. PMID: 27688049.
      Citations: 1     Fields:    Translation:Humans
    149. Yoo ER, Perumpail RB, Cholankeril G, Ahmed A. Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome. Case Rep Infect Dis. 2016; 2016:2605302. PMID: 27847658; PMCID: PMC5101374.
      Citations:    
    150. Perumpail RB, Yoo ER, Cholankeril G, Hogan L, Deis M, Concepcion WC, Bonham CA, Younossi ZM, Wong RJ, Ahmed A. Underutilization of Living Donor Liver Transplantation in the United States: Bias against MELD 20 and Higher. J Clin Transl Hepatol. 2016 Sep 28; 4(3):169-174. PMID: 27777886; PMCID: PMC5075001.
      Citations: 1     
    151. Cholankeril G, Yoo ER, Perumpail RB, Younossi ZM, Ahmed A. Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices. Clin Gastroenterol Hepatol. 2017 02; 15(2):313-315. PMID: 27609705.
      Citations: 3     Fields:    Translation:Humans
    152. Cholankeril G, Perumpail RB, Pham EA, Ahmed A, Harrison SA. Nonalcoholic Fatty Liver Disease: Epidemiology, Natural History, and Diagnostic Challenges. Hepatology. 2016 09; 64(3):954. PMID: 27388553.
      Citations: 6     Fields:    Translation:Humans
    153. Yoo ER, Perumpail RB, Cholankeril G, Jayasekera CR, Ahmed A. Task-shifting - A practical strategy to improve the global access to treatment for chronic hepatitis C. Int J Nurs Stud. 2016 Oct; 62:168-9. PMID: 27497192.
      Citations: 2     Fields:    Translation:Humans
    154. Cholankeril G, Perumpail RB, Tulu Z, Jayasekera CR, Harrison SA, Hu M, Esquivel CO, Ahmed A. Trends in Liver Transplantation Multiple Listing Practices Associated With Disparities in Donor Availability: An Endless Pursuit to Implement the Final Rule. Gastroenterology. 2016 09; 151(3):382-386.e2. PMID: 27456386.
      Citations: 1     Fields:    Translation:Humans
    155. Cholankeril G, Hu M, Tanner E, Cholankeril R, Reha J, Somasundar P. Skilled nursing facility placement in hospitalized elderly patients with colon cancer. Eur J Surg Oncol. 2016 Nov; 42(11):1660-1666. PMID: 27387271.
      Citations: 4     Fields:    Translation:Humans
    156. Cholankeril G, Perumpail RB, Hu M, Skowron G, Younossi ZM, Ahmed A. Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C. Dig Dis Sci. 2016 09; 61(9):2505-15. PMID: 27084385.
      Citations: 3     Fields:    Translation:Humans
    157. Ahmad A, Khan H, Cholankeril G, Katz SC, Somasundar P. The impact of age on nodal metastases and survival in gastric cancer. J Surg Res. 2016 05 15; 202(2):428-35. PMID: 27229119.
      Citations: 5     Fields:    Translation:Humans
    CHOLANKERIL's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (313)
    Explore
    _
    Co-Authors (15)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _